 |
 |

Solitary Idiopathic Choroiditis
The Richard B. Weaver Lecture
Jerry A. Shields, MD;
Carol L. Shields, MD;
Hakan Demirci, MD;
Santosh Hanovar, MD
Arch Ophthalmol. 2002;120:311-319.
ABSTRACT
 |  |
Objective To report the clinical characteristics of solitary idiopathic choroiditis
and the features that differentiate it from tumors and other inflammatory
lesions.
Design Retrospective medical record review.
Patients Sixty consecutive patients with solitary idiopathic choroiditis.
Main Outcome Measures Clinical features, natural course, and follow-up.
Results The mean and median ages of the patients were 35 and 36 years, respectively,
56 (93%) of the 60 patients were white, 38 (63%) were female, and 22 (37%)
were male. No patient had a history, clinical findings, or laboratory study
results to support a specific cause of uveitis. All were referred to us because
of a suspected intraocular tumor. The patient was asymptomatic in 21 cases
(35%); the patient had mild visual loss in 36 cases (60%). The lesion was
posterior to the equator in 56 cases (93%), was yellow in 58 cases (97%),
and had distinct margins in 38 cases (63%). The lesion showed signs of active
inflammation in 20 cases (33%) and no inflammation in 40 cases (67%). Fluorescein
angiography disclosed that all lesions had early hypofluorescence and late
hyperfluorescence. In the late-phase angiograms inactive lesions had distinct
margins and active lesions had ill-defined margins. Lesions with active inflammation
appeared to show a favorable response to the administration of systemic corticosteroids
but generally improved with or without treatment. Most of the inactive lesions
remained stable on long-term follow-up. Overall, the condition remained stable
in 36 patients (60%), improved in 22 (37%), and recurred in 2 (3%). The clinical
and angiographic features and clinical course of solitary idiopathic choroiditis
were generally different from known intraocular tumors.
Conclusions Solitary idiopathic choroiditis is a distinct clinical entity that can
simulate an intraocular neoplasm. Recognition of its typical clinical features
can assist in differentiating it from tumors and other inflammatory lesions
of the ocular fundus.
INTRODUCTION
CHOROIDITIS USUALLY occurs as multifocal lesions, often with signs of
generalized ocular inflammation.1 Sometimes,
however, choroiditis can manifest as a solitary lesion. Conditions known to
manifest as a solitary choroidal granuloma include sarcoidosis, tuberculosis,
toxocariasis, or several other diseases.1 In
many instances, however, solitary choroiditis remains idiopathic, in spite
of extensive systemic evaluation.2-3
Even when uveal granulomas are subjected to detailed histopathologic studies,
no cause can be determined in many cases.2
Such solitary idiopathic choroiditis (SIC) can simulate clinically an amelanotic
choroidal tumor, like nevus, melanoma, metastasis, or osteoma, or a retinal
tumor like retinoblastoma or astrocytic hamartoma.4-6
We describe our experience with 60 patients with SIC, who were referred because
of a suspected tumor, and we elucidate the features that differentiate SIC
from tumors and other type of inflammations.
PATIENTS AND METHODS
A medical record review was performed for patients clinically or by
mail consultation seen on the Ocular Oncology Service, Wills Eye Hospital,
Philadelphia, Pa, who were diagnosed as having unifocal choroiditis, for which
no apparent cause was determined. General data collected included age at diagnosis,
race, sex, eye involved, and medical and ocular histories. Prior treatment
for the ocular lesion and the referral diagnoses were listed. The manifesting
symptoms, visual acuities, intraocular pressures (IOPs), and results of slitlamp
biomicroscopy were tabulated. The results of studies for specific causes of
intraocular inflammation were reviewed when available. These included physical
and ocular findings, chest x-ray film, and conventional methods to rule out
sarcoidosis, tuberculosis, histoplasmosis, syphilis, toxoplasmosis, toxocariasis,
Lyme disease, cat-scratch disease, and other conditions when indicated. Since
the results of these studies were uniformly negative in all of the early patients,
most asymptomatic patients with inactive lesions were subsequently not subjected
to the time and expense of extensive systemic evaluation.
Fundus drawings and photographs, done for all patients, were reviewed.
We determined the ocular zone in which the main portion of the lesion was
located (macular, juxtapapillary, between the macular area and the equator,
or between the equator and the ora serrata). Macular was defined as the area
extending for 2 disc diameters (3.0 mm) from the foveola in any direction.
A juxtapapillary lesion was defined as one that touched or covered the margin
of the optic disc. If a lesion touched the optic disc on the temporal side,
it was classified as juxtapapillary, rather than macular, in this study. The
main retinal sector affected by the lesion was determined (inferior, nasal,
superior, and temporal).
Data related to the fundus lesion itself included the basal size, distance
of the margin of the lesion from foveola and optic nerve, signs of active
inflammation (vitreous cells and hazy margins of the lesion), color (yellow,
yellow-white, or orange), characteristics of the margins (distinct, indistinct,
or surrounded by an orange halo), and associated changes in the retinal pigment
epithelium. The presence and extent of exudation, hemorrhage, subretinal fluid,
retinal or vitreal inflammation, and the presence of a choroidal neovascular
membrane and retinochoroidal vascular anastamoses were determined. The method
of management was reviewed. Follow-up information included visual acuity;
IOP; size, color, and margins of the lesion; signs of recurrent inflammation;
presence of an orange halo; retinal pigment epithelial changes; presence of
exudation, hemorrhage, or subretinal fluid; presence of a choroidal neovascular
membrane; status of the optic disc; and final status of the globe with regard
to visual acuity and appearance of the lesion (stable, improved, or worse).
Since most patients were referred to us for suspicion of an intraocular neoplasm,
we specifically reviewed the features that were helpful in differentiating
SIC from intraocular tumors such as choroidal metastasis, choroidal hemangioma,
amelanotic nevus, amelanotic melanoma, osteoma, and other ocular tumors and
pseudotumors.
RESULTS
Sixty consecutive patients had SIC. Demographic information for these
patients is given in Table 1.
No patient had a history of intraocular inflammation, ocular trauma, or ocular
surgery. No patient had systemic findings of sarcoidosis, tuberculosis, histoplasmosis,
syphilis, toxoplasmosis, toxocariasis, Lyme disease, cat-scratch disease,
pneumocystosis, blastomycosis, coccidioidomycosis, aspergillosis, herpes simplex,
herpes zoster, or human immunodeficiency virus infection. Other than symptoms
related to the choroidal lesion, no patient had prior ocular problems.
|
|
|
|
Table 1. Demographic Findings in 60 Consecutive Patients With Solitary
Idiopathic Choroiditis
|
|
|
Of the 60 patients, 16 (27%) had received prior treatment elsewhere
for the fundus lesion, including systemic corticosteroids in 7 patients (12%),
topical corticosteroids in 3 patients (5%), both systemic and topical corticosteroids
in 3 patients (5%), periocular corticosteroids in 1 patient (2%), systemic
corticosteroids and laser treatment in 1 patient (2%), and vitreous biopsy
and laser treatment in 1 patient (2%). The other 32 patients were referred
directly to us or had no prior treatment. The main referral diagnoses are
given in Table 2. In every case,
there was consideration of an intraocular tumor, prompting referral to the
Ocular Oncology Service. Patient symptoms are listed in Table 3. Mild visual symptoms were present in 39 patients (65%)
and 21 patients (35%) were asymptomatic, with the lesion discovered on routine
ophthalmic examination.
|
|
|
|
Table 2. Referral Diagnosis of 60 Consecutive Patients With Solitary
Idiopathic Choroiditis*
|
|
|
|
|
|
|
Table 3. Symptoms of 60 Patients With Solitary Idiopathic Choroiditis
|
|
|
The visual acuity in the affected eye was 20/20 in 24 patients (40%),
20/25 to 20/40 in 15 (25%), 20/50 to 20/100 in 9 (15%), and 20/400 to finger
counting in 10 (17%). A visual acuity of hand motions was recorded in 1 patient
and no light perception in 1 patient (advanced optic disc granuloma). The
mean IOP was 17 mm Hg, with a median of 16 mm Hg, and a range of 5 to 31 mm
Hg. An IOP greater than 22 mm Hg was recorded in 6 patients; in no case was
the elevated IOP believed to be due to the choroidal lesion. The anterior
segment findings as noted with slitlamp biomicroscopy are summarized in Table 4. Only 5 (8%) of 60 patients had
inflammatory cells in the anterior chamber and the 3 cataracts did not seem
to be directly related to the choroidal inflammation.
|
|
|
|
Table 4. Clinical Findings of 60 Consecutive Patients With Solitary
Idiopathic Choroiditis
|
|
|
The retinal zones and the fundus sectors in which the lesion was mainly
located are listed in Table 4.
The lesion was located posterior to the equator in 56 cases (93%), specifically
in the macular area in 17 cases (28%), in a juxtapapillary location in 8 cases
(13%), and between the macular area and the equator in 31 cases (52%).
Other ophthalmoscopic findings are listed in Table 4. They varied depending on whether the lesion was dormant
(Figure 1) or had signs of active
inflammation (Figure 2). Of the
60 lesions, 40 (67%) had minimal or no inflammatory signs and we categorized
them as inactive. The other 20 active lesions (33%) had ill-defined margins
(Figure 2) and had caused mild visual
symptoms and contained vitreous cells, fresh exudation, and localized subretinal
fluid.
|
|
|
|
Figure 1. Fluorescein angiography of inactive
lesion of solitary idiopathic choroiditis. A, Clinical appearance of the lesion
superior to the optic disc. B, Arterial phase shows relative hypofluorescence
of the lesion. C, Late phase shows intense hyperfluorescence of the lesion.
Note that the margins of the lesion are distinct.
|
|
|
|
|
|
|
Figure 2. Fluorescein angiography of an
active lesion of solitary idiopathic choroiditis. A, Clinical appearance of
lesion superior to the fovea. Note the stellate-shaped exudation in the fovea
(to the left) and the surrounding retinal detachment with lipoproteinaceous
exudation. B, Arterial phase shows faint hyperfluorescence of the lesion and
more intense hypofluorescence surrounding the lesion, corresponding to blockage
by the subretinal exudation. C, Late recirculation phase shows intense hyperfluorescence
of the lesion with hazy margins due to fluorescein leakage from the mass.
|
|
|
The results of fluorescein angiography (37 patients), indocyanine green
angiography (6 patients), and ultrasonography (36 patients) are given in Table 5. With fluorescein angiography,
the inactive lesions generally showed early hypofluorescence, progressive
hyperfluorescence, and a distinct margin in the later angiograms (Figure 1). Active lesions displayed early
hypofluorescence followed by late leakage from the lesion into the subretinal
fluid or the vitreous cavity (Figure 2).
Indocyanine green angiography showed findings that paralleled the fluorescein
angiography, with early hypofluorescence and late mild hyperfluorescence.
No retinal or choroidal neovascularization was identified, but 3 lesions showed
mild retinochoroidal anastomosis (Figure 1H). Ultrasonography showed no diagnostic features and the lesions
generally had medium to high internal reflectivity.
|
|
|
|
Table 5. Diagnostic Testing of 60 Consecutive Patients With Solitary
Idiopathic Choroiditis
|
|
|
Because of the variations in treatment in our case series, it was impossible
to determine the overall response to treatment. However, it was our impression
that lesions with active inflammation generally had a favorable response to
therapeutic systemic corticosteroids; no patient's condition became worse
while receiving corticosteroids.
Follow-up data for the patients in this study ranged from 6 months to
25 years (mean, 24 months). The systemic, ocular, and visual outcomes are
listed in Table 6. Most lesions
remained stable or improved. There was recurrence of the activity of the lesion
in 4 cases (12%), but only 2 patients (6%) had worsening of visual acuity
during follow-up.
|
|
|
|
Table 6. Outcomes of 60 Consecutive Patients With Solitary Idiopathic
Choroiditis
|
|
|
In the evaluation of these patients and in the medical record review,
particular attention was paid to the clinical features that help to differentiate
SIC from other intraocular tumors and pseudotumors. These differential features
are covered in the subsequent discussion.
COMMENT
Most cases of posterior segment intraocular inflammation have cells
in the anterior chamber and vitreous and multifocal or bilateral lesions of
the choroid or retina. In such cases, a clinical evaluation is usually undertaken
to detect a specific cause and treatment is directed toward the underlying
cause(s). There is little in the literature about the condition described
in this study. Our 60 consecutive patients had SIC lesions for which intraocular
tumor was a diagnostic consideration. The origin was unknown in all cases
despite systemic evaluation for causes of uveitis in many cases.
A series of 6 cases of unifocal choroiditis was reported in 1997 by
Hong et al,3 who used the term "unifocal helioid
choroiditis" because of the sunlike appearance of the yellow lesion. Their
patients were all symptomatic, having blurred vision, metamorphopsia, or scotoma.
In our case series, 39 patients (65%) were symptomatic and 21 (35%) were asymptomatic
(ie, the lesion was found on routine ophthalmic examination). All were referred
to us to exclude the possibility of an intraocular tumor. We chose the descriptive
term "solitary idiopathic choroiditis" to define this entity.
Solitary idiopathic choroiditis can occur at any age, but most patients
are between 20 and 50 years old at the time of diagnosis. There seems to be
no predilection for sex, race, or laterality. The medical history, ocular
history, and systemic study results fail to reveal a specific cause. This
is not surprising, since Margo and Zimmerman2
performed detailed histopathologic studies on 11 enucleated eyes with solitary
granulomas, in which no cause could be determined.
The visual acuity is generally good, unless the lesion occurs in a juxtapapillary
or foveal location. The IOPs are normal and there usually are no signs of
anterior segment inflammation. Most lesions occur posterior to the equator.
Solitary idiopathic choroiditis has typical ophthalmoscopic features
that vary depending on whether the lesion is inactive or active.
In the inactive stage, SIC appears as a discrete, nummular, yellow-white
lesion. A highly characteristic sign, seen in some cases, is an ill-defined
red-orange halo that surrounds the lesion (Figure 3C). Retinal pigment epithelial abnormalities are usually
minimal. Retinochoroidal shunt vessels are occasionally present (Figure 3G). In the active stage, SIC usually
appears as a dull-yellow choroidal lesion with an ill-defined margin, yellow
intraretinal exudation, localized subretinal fluid and occasional retinal
vascular dilation, and focal retinal hemorrhages (Figure 4). The exudation sometimes can assume a stellate configuration
in the foveal area often separate from the main lesion (Figure 2A). As the inflammation subsides, the margins become better
defined and exudation, hemorrhage, subretinal fluid, and vascular abnormalities
disappear. Margo and Zimmerman2 speculated
that the advanced findings seen in their case series represented the more
severe form of the disease and that the clinical features of the less severe
cases were unknown. It is possible that our cases represent this less severe
form of what they described.
|
|
|
|
Figure 3. Clinical spectrum of presumed
inactive solitary idiopathic choroiditis. A, Well-defined, yellow, inactive
lesion inferior to the optic disc in a 23-year-old woman. The patient experienced
recurrent bouts of inflammation for 26 years after this photograph was taken.
B, Well-defined, inactive juxtapapillary lesion, touching superior margin
of optic disc in a 43-year-old man. C, Juxtapapillary lesion inferonasal to
the optic disc in a 30-year-old woman shows a characteristic red-orange halo.
D, Discrete lesion superior to the optic disc in a 37-year-old man. E, Same
lesion (Figure 1D) shown in 3-dimension after 2 years. Note that it is stable
in size but has developed mild pigmentary mottling on the surface. F, Lesion
inferior to the optic disc with mild overlying proliferation of the retinal
pigment epithelium in a 30-year-old man. G, Small juxtafoveal lesion with
a superficial retinal arteriovenous communication in a 13-year-old girl. H,
Juxtafoveal lesion with retinal arteriovenous communication in a 47-year-old
woman. There is a small amount of residual intraretinal exudation inferior
to the lesion. Prior subretinal fluid has resolved.
|
|
|
|
|
|
|
Figure 4. Clinical spectrum of active lesions
of solitary idiopathic choroiditis showing a response to treatment and resultant
complications. A, Juxtafoveal lesion in a 12-year-old boy with blurred vision.
The active lesion has an ill-defined border and subretinal fluid is present
in the entire macular region. Consultation with infectious disease experts
and exhaustive laboratory studies failed to uncover a cause. The patient was
treated with oral corticosteroids. B, Lesion shown in Figure 2A after 3 weeks
of oral corticosteroid therapy. The lesion is smaller and more discrete, the
subretinal fluid has resolved, and the visual acuity has dramatically improved
to 20/20. C, Juxtapapillary lesion in a 25-year-old woman. There is partially
resolved exudation and subretinal fluid in the foveal area. Note the peculiar
retinal vascular tortuosity on the surface of the lesion. The patient was
treated with oral corticosteroids. D, Lesion shown in Figure 2C after 2 years.
The exudation and subretinal fluid have subsided. E, Juxtafoveal lesion in
a 12-year-old girl with sudden onset of blurred vision. The lesion responded
to oral corticosteroid therapy. F, Lesion shown in Figure 2E after 2 years.
The lesion is larger and associated with continued inflammatory signs. G,
Typical lesion inferior to the optic disc in a 60-year-old woman. The patient
was asymptomatic. H, Lesion shown in Figure 2G 6 years later when patient
had floaters. There is a superficial hemorrhage along the course of a retinal
artery that passes over the lesion.
|
|
|
Fluorescein angiography of SIC varies with the activity of the lesion
(Table 5). An inactive lesion
shows early relative hypofluorescence and intense late staining, with a clearly
defined margin (Figure 1). An active
lesion also shows hypofluorescence in the vascular-filling phases and progressive
hyperfluorescence in the later angiograms, with a poorly defined margin due
to leakage into adjacent subretinal fluid and vitreous (Figure 4). The SIC is usually a small lesion and ultrasonography
is of little diagnostic value.
The etiology of SIC is unknown. A choroidal granuloma secondary to sarcoidosis,7-10 tuberculosis,4-5,11-15
ocular toxocariasis,16 cat-scratch disease,17 and other conditions can assume a similar clinical
appearance and clinical course. Most of these entities can be diagnosed by
history, clinical findings, and laboratory test results. None of the patients
in our case series had findings suggestive of the aforementioned diseases.
Inflammatory conditions like ocular histoplasmosis, retinal toxoplasmosis,
nocardiosis, intraocular abscess, and syphilis usually have a different clinical
appearance1 and are usually not serious considerations
in the differential diagnosis of SIC.
It is tempting to speculate that the condition described herein represents
a focal granuloma. However, multifocal choroiditis, often considered to be
a granulomatous process, has been shown histopathologically in one case to
represent a nongranulomatous inflammation.18
Since we have no histopathologic confirmation on our case series, we have
chosen to call this condition SIC and to avoid the term "granuloma" at this
time. It is tempting to speculate that SIC is in the spectrum of other ocular
inflammations like nodular posterior scleritis or orbital inflammatory pseudotumor,
where a specific etiologic agent is not demonstrable.
Most of our patients with SIC were referred to us because of diagnostic
uncertainty and because intraocular tumor was a consideration. Therefore,
the main goal of this study was to clarify the clinical manifestations of
SIC and to review the clinical features that serve to differentiate it from
specific inflammatory processes, fundus tumors, choroidal neovascular membranes,
organized hemorrhage, and other conditions that may have a similar clinical
appearance.
Concerning inflammatory conditions, SIC may be similar clinically to
a choroidal granuloma of sarcoidosis, tuberculosis, or other related entities.
None of our patients had a history, clinical findings, or positive laboratory
study results to suggest known granulomatous disease. However, we cannot absolutely
exclude these conditions since it is possible that they could produce a solitary
granuloma as the only manifestation of the disease. As a rule, however, these
conditions produce more severe inflammatory disease, with anterior uveitis
and vitreous inflammatory cells. In our case series, anterior segment and
vitreous inflammation was usually absent or very subtle.
Other ocular inflammatory conditions that may superficially resemble
SIC include ocular histoplasmosis, ocular toxoplasmosis, nodular posterior
scleritis, syphilis, and cat-scratch disease, but there are features that
should assist in differentiating them from SIC.1
Ocular histoplasmosis most often affects the eye as a classic triad of juxtapapillary
choroidal atrophy, peripheral discrete lesions, and a macular neovascular
membrane. Ocular toxoplasmosis primarily affects the retina and not the choroid,
usually produces more vitreous cellular reaction, is likely to have satellite
lesions, and heals as a flat or punched-out scar with more pigment proliferation
than seen in our patients.19 Nodular posterior
scleritis has a faint orange-red color similar to the background fundus, is
often associated with choroidal folds, and shows characteristic multiple hyperfluorescent
spots on angiography.20 Syphilis can rarely
produce a posterior choroidal granuloma. However, it more often appears as
a solitary, placoid, pale-yellow lesion that lacks the yellow-white color
and distinct margins that characterize SIC.21
Cat-scratch disease is recognized to produce a variety of intraocular inflammatory
signs. Usually it occurs as an optic papillitis with a stellate macular exudation.
One reported case of presumed cat-scratch disease was seen as a solitary mass
that was identical to the cases reported herein.17
Some of our patients were seen prior to the widespread recognition of cat-scratch
disease as a cause of intraocular inflammation. Therefore, they did not undergo
serologic studies for bartonellosis. However, none of our patients had a history
of excessive contact with cats.
As demonstrated from our study, SIC may be clinically similar to ocular
tumors like amelanotic choroidal melanoma, amelanotic choroidal nevus, choroidal
metastasis, solitary choroidal hemangioma, choroidal osteoma, lymphoma, retinoblastoma,
or retinal astrocytic hamartoma.22-26
Amelanotic choroidal melanoma differs from SIC in that it tends to be
larger in diameter and thickness, often has visible blood vessels within the
mass, usually has a less distinct margin, does not produce yellow exudation,
does not have a surrounding red halo, and often has overlying drusen or golden-brown
pigment mottling. Amelanotic choroidal nevus has similar features to amelanotic
choroidal melanoma except it is usually smaller.
Choroidal metastasis tends to have a duller, creamy yellow color, usually
has less distinct margins, does not produce appreciable inflammation or exudation,
causes more extensive retinal detachment, and generally shows less intense
late fluorescence on angiography. Solitary choroidal hemangioma tends to have
a more red-orange color, has slightly ill-defined margins, usually lacks yellow
exudation, and shows diffuse mottled fluorescence by the arterial phase and
moderately intense late staining on angiography. Choroidal osteoma has a yellow-orange
color and well-defined margins but has more irregular or scalloped borders,
lacks inflammatory signs, and produces a very highly reflective echo on ultrasonography,
a bone density pattern with computed topography, and is more likely to cause
choroidal neovascularization. Intraocular lymphoma can sometimes occur as
a solitary lesion in the choroid, retina, or beneath the retinal pigment epithelium.
It has clinical and angiographic features similar to a choroidal metastasis.
It frequently occurs in patients who have concurrent systemic lymphoma.
A small retinoblastoma occurs in younger patients, is located in the
retina rather than the choroid, and has retinal feeding and draining blood
vessels that are derived from the sensory retina. Chalky white foci of calcification
are occasionally seen in retinoblastoma. Retinal astrocytic hamartoma usually
has a gray-white rather than yellow-white color, is located in the sensory
retina rather than the choroid, and may show glistening yellow foci of calcification;
findings not seen with SIC.
The diagnostic evaluation of a patient with ophthalmoscopic findings
of SIC should depend on the clinical findings. If the lesion shows signs of
active inflammation and the visual acuity is affected, a systemic evaluation
for the aforementioned specific inflammatory conditions is justified. In most
instances, clinical testing for various causes of uveitis yields negative
results. Since many of the inactive lesions are asymptomatic and are unlikely
to recur, evaluation should be limited to testing for treatable conditions
like sarcoidosis, tuberculosis, and syphilis. If positive results are found,
then a course of appropriate treatment should be considered. Negative results
would support the diagnosis of SIC.
The management of SIC varies with the clinical findings. If the lesion
appears inactive and is discovered on routine ophthalmic examination, periodic
observation only is warranted. Active lesions in the region of the optic disc
or fovea should be treated with systemic corticosteroids in a traditional
manner.
CONCLUSION
We have described the clinical features of 60 cases of a rather distinct
clinical entity, which we have called SIC. It has features similar to solitary
granulomas that can occur with ocular sarcoidosis, tuberculosis, and toxocariasis,
but clinical and laboratory studies fail to reveal a specific cause. Although
it can superficially resemble several amelanotic intraocular tumors like choroidal
melanoma, metastasis, hemangioma, osteoma, lymphoma, retinoblastoma, and retinal
astrocytic hamartoma, it has distinctive clinical and fluorescein angiographic
features that should differentiate it from most intraocular tumors. The patient
should have limited systemic and laboratory studies to determine a specific
cause, but most cases will remain idiopathic. If vision is threatened, therapeutic
systemic or periocular corticosteroids should be administered. In contrast
to most malignant tumors, SIC is a self-limited disease, but it may occasionally
display recurrent bouts of inflammation. However, it generally stabilizes
and usually does not show progressive enlargement. It is important for clinicians
to be familiar with SIC and to differentiate SIC from other inflammatory conditions
and tumors to avoid misdirected therapy.
AUTHOR INFORMATION
Submitted for publication July 12, 2001; final revision received September
25, 2001; accepted December 11, 2001.
This study was supported in part by the Eye Tumor Research Foundation,
Philadelphia; the Award of Merit in Retina Research, Houston, Tex (Dr J. A.
Shields); and the Macula Foundation, New York, NY (Dr C. L. Shields).
Corresponding author and reprints: Jerry A. Shields, MD, Ocular Oncology
Service, Wills Eye Hospital, 900 Walnut St, Philadelphia, Pa 19107.
From the Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson
University, Philadelphia, Pa.
REFERENCES
 |  |
1. Nussenblatt RB, Whitcup SM, Palestine AG. Uveitis. In: Fundamentals and Clinical Practice.
St Louis, Mo: MosbyYear Book Inc; 1996:155-385.
2. Margo C, Zimmerman LE. Idiopathic solitary granuloma of the uveal tract. Arch Ophthalmol. 1984;102:732-735.
ABSTRACT
3. Hong PH, Jampol LM, Dodwell DG, Hrisomalos NF, Lyon AT. Unifocal helioid choroiditis. Arch Ophthalmol. 1997;115:1007-1013.
ABSTRACT
4. Shields JA, Shields CL. Differential diagnosis of posterior uveal melanoma: chorioretinal granuloma. In: Intraocular Tumors: A Text and Atlas.
Philadelphia, Pa: WB Saunders Co; 1992:145-146.
5. Shields JA, Shields CL. Lesions simulating posterior uveal melanoma: choroidal granuloma. In: Atlas of Intraocular Tumors. Philadelphia,
Pa: Lippincott Williams & Wilkins; 1999:146-147.
6. Gunduz K, Shields CL, Shields JA, Schubert H. Presumed choroidal granuloma with vitreous hemorrhage resembling choroidal
melanoma. Ophthalmic Surg Lasers. 1998;29:422-425.
PUBMED
7. Marcus DF, Bovino JA, Burton TC. Sarcoid granuloma of the choroid. Ophthalmology. 1982;89:1326-1330.
ISI
| PUBMED
8. Olk RJ, Lipmann MJ, Cundiff HC, Daniels J. Solitary choroidal mass as the presenting symptom in systemic sarcoidosis. Br J Ophthalmol. 1983;67:826-829.
FREE FULL TEXT
9. Campo RV, Aaberg TM. Choroidal granuloma in sarcoidosis. Am J Ophthalmol. 1984;97:419-427.
PUBMED
10. Tingey DP, Gonder JR. Ocular sarcoidosis presenting as a solitary choroidal mass [review]. Can J Ophthalmol. 1992;27:25-29.
PUBMED
11. Cangemi FE, Friedman AH, Josephberg R. Tuberculoma of the choroid. Ophthalmology. 1980;87:252-256.
ISI
| PUBMED
12. Smith RE. Tuberculoma of the choroid [discussion]. Ophthalmology. 1980;87:257-258.
13. Jabbour NM, Faris B, Trempe CL. A case of pulmonary tuberculosis presenting with a choroidal tuberculoma. Ophthalmology. 1985;92:834-837.
ISI
| PUBMED
14. Lyon CE, Grimson BS, Peiffer RL Jr, Merritt JC. Clinicopathological correlation of a solitary choroidal tuberculoma. Ophthalmology. 1985;92:845-850.
ISI
| PUBMED
15. Mansour AM, Haymond R. Choroidal tuberculomas without evidence of extraocular tuberculosis. Graefes Arch Clin Exp Ophthalmol. 1990;228:382-385.
FULL TEXT
|
ISI
| PUBMED
16. Shields JA. Ocular toxocariasis: a review. Surv Ophthalmol. 1984;28:361-381.
FULL TEXT
|
ISI
| PUBMED
17. Pollock SC, Kristinsson J. Cat-scratch disease manifesting as unifocal helioid choroiditis. Arch Ophthalmol. 1998;116:1249-1251.
FREE FULL TEXT
18. Dunlop AA, Cree IA, Hague S, Luthert PJ, Lightman S. Multifocal choroiditis: clinicopathologic correlation. Arch Ophthalmol. 1998;116:801-803.
FREE FULL TEXT
19. Ramadan AM, Nussenblatt RB. Toxoplasmosis. In: Guyer DR, Yannuzzi L, Chang S, Shields JA, Green WR, eds. Retina-Vitreous-Macula: A Color Text. Philadelphia, Pa:
WB Saunders Co; 1997:671-708.
20. Benson WE, Shields JA, Tasman W, Crandall AS. Posterior scleritis: a cause of diagnostic confusion. Arch Ophthalmol. 1979;97:1482-1486.
ABSTRACT
21. Ho AC. Ocular syphilis. In: Guyer DR, Yannuzzi L, Chang S, Shields JA, Green WR, eds. Retina-Vitreous-Macula: A Color Text. Philadelphia, Pa:
WB Saunders Co; 1997:793-800.
22. Shields JA, Shields CL. Clinical features of posterior uveal melanoma. In: Atlas of Intraocular Tumors. Philadelphia,
Pa: Lippincott Williams & Wilkins; 1999:74-93.
23. Brown GC, Shields JA, Augsburger JJ. Amelanotic choroidal nevi. Ophthalmology. 1981;88:1116-1121.
ISI
| PUBMED
24. Shields CL, Shields JA, Gross NE, Schwartz GP, Lally SE. Survey of 520 uveal metastases. Ophthalmology. 1997;104:1265-1276.
ISI
| PUBMED
25. Shields CL, Shields JA, Augsburger JJ. Choroidal osteoma [review]. Surv Ophthalmol. 1988;33:17-27.
FULL TEXT
|
ISI
| PUBMED
26. Shields JA, Shields CL. Intraocular lymphoid tumors and leukemias. In: Atlas of Intraocular Tumors. Philadelphia,
Pa: Lippincott Williams & Wilkins; 1999:324-330.
RELATED ARTICLE
Archives of Ophthalmology Reader's Choice: Continuing Medical Education
Arch Ophthalmol. 2002;120(3):411-412.
FULL TEXT
|